Skip to content

Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas

Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas: A Three-Year Retrospective Case Series From Eastern Morocco

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07723365
Acronym
epidemiology
Enrollment
20
Registered
2026-07-23
Start date
2023-01-01
Completion date
2026-06-01
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinomas (Including Squamous Cell and Adenocarcinoma)

Keywords

carcinomas, epidemiologie, surgery

Brief summary

Twenty patients were included, comprising 11 women (55%) and 9 men (45%), with a mean age of 63.1 years. Chronic sun exposure was identified in 18 patients (90%). The lower eyelid was the most commonly affected site in 9 cases (45%). Basal cell carcinoma accounted for 15 tumors (75%), followed by squamous cell carcinoma in 5 cases (25%). Wide local excision with histopathological margin control was performed in all patients (20/20, 100%), and orbital exenteration was required in 1 case (5%). Reconstruction was achieved mainly using local flaps in 12 patients (60%). Ectropion occurred in 2 patients (10%). No local recurrence was observed during a mean follow-up of 22 months.

Detailed description

This retrospective study was conducted over a three-year period, from January 2023 to December 2025, and included 20 patients with eyelid carcinomas who underwent surgical treatment in the Department of Plastic and Reconstructive Surgery at Mohammed VI University Hospital. Demographic, clinical, histological, therapeutic, and outcome data were analyzed.

Interventions

None listed

Sponsors

Mohammed VI University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patient with carcinoma

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frame
Eyelid carcinomasfrom January 2023 to December 2025

Countries

Morocco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026